A team from the Hong Kong University of Science and Technology (HKUST) has recently developed a new technology that could increase synthetic mRNA’s protein production efficiency, thereby strengthening the efficiency of cancer treatments and COVID-19 vaccines.
The finding was recently published in the online version of the journal Molecular Therapy—Nucleic Acids.
mRNA is a genetic material replicated from the nucleus of DNA. It functions as a messenger and instructs the body to produce certain proteins.
Synthesis of mRNAs is an emerging technology that has been used to produce vaccines and medicines in recent years, which can instruct the production of protein from the cells for treating cancers and fighting viruses….